首页> 外文OA文献 >Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells
【2h】

Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells

机译:蒽吡啶酮类,一组新的抗肿瘤非交叉耐药性蒽醌类似物。对K562 / DOX细胞杀伤活性的合成及其分子基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multidrug resistance (MDR) to antitumour agents, structurally dissimilar and having different intracellular targets, is the major problem in cancer therapy. MDR phenomenon is associated with the presence of membrane proteins which belong to the ATP-binding cassette family transporters responsible for the active drug efflux leading to the decreased intracellular accumulation.The search of new compounds able to overcome MDR is of prime importance.Recently we have synthesized a new family of anthrapyridone compounds. The series contained derivatives modified with appropriate hydrophobic or hydrophylic substituents at the side chain.The interaction of these derivatives with erythroleukemia K562 sensitive and K562/DOX resistant (overexpressing P-glycoprotein) cell lines has been examined. The study was performed using a spectrofluorometric method which allows to continuously follow the uptake and efflux of fluorescent molecules by living cells.It was demonstrated that the increase in the lipophilicity of anthrapyridones favoured the very fast cellular uptake exceeding the rate of P-gp dependent efflux out of the cell. For these derivatives, very high accumulation (the same for sensitive and resistant cells) was observed and the in vitro biological data confirmed that these compounds exhibited comparable cytotoxic activity towards sensitive and P-gp resistant cell line. In contrast, anthrapyridones modified with hydrophylic substituents exhibited relatively low kinetics of cellular uptake.For these derivatives decreased accumulation in resistant cells was observed and the in vitro biological data demonstrated that they were much less active against P-gp resistant cells in comparison to sensitive cells.We also studied, using confocal microscopy, the intracellular distribution of anthrapyridones in NIH-3T3 cells. Our data showed that these compounds were strongly accumulated in the nucleus and lysosomes.
机译:对结构不同且具有不同细胞内靶标的抗肿瘤药物的多药耐药性(MDR)是癌症治疗中的主要问题。 MDR现象与膜蛋白的存在有关,这些膜蛋白属于负责活性药物外排的ATP结合盒家族转运蛋白,导致细胞内积累减少。寻找能够克服MDR的新化合物至关重要。合成了蒽吡啶酮化合物的新家族。该系列包含在侧链上被适当的疏水或疏水取代基修饰的衍生物。已经研究了这些衍生物与红白血病K562敏感和K562 / DOX抗药性(过表达P-糖蛋白)细胞系的相互作用。该研究采用分光荧光法进行,该方法可以连续跟踪活细胞对荧光分子的吸收和流出情况。研究表明蒽吡啶酮的亲脂性增加有利于非常快速的细胞吸收,超过了P-gp依赖的流出速度走出牢房。对于这些衍生物,观察到非常高的积累(对于敏感和抗性细胞而言相同),并且体外生物学数据证实这些化合物对敏感和P-gp抗性细胞系表现出相当的细胞毒性活性。相比之下,经亲水取代基修饰的蒽吡啶酮表现出较低的细胞摄取动力学。对于这些衍生物,观察到耐药细胞中的积累减少,并且体外生物学数据表明与敏感细胞相比,它们对P-gp耐药细胞的活性低得多我们还使用共聚焦显微镜研究了蒽吡啶酮在NIH-3T3细胞中的细胞内分布。我们的数据表明,这些化合物强烈聚集在细胞核和溶酶体中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号